PEOPLE - Axis-Shield makes appointment:
This article was originally published in Clinica
Anglo-Norwegian IVDs manufacturer Axis-Shield (Dundee and Oslo) has appointed Ronny Hermansen as finance director, in place of Paul Garvey, who is leaving the company. Mr Hermansen is known for his financial expertise in the Norwegian pharma sector.
You may also be interested in...
Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.
Sawai’s sales increased on the back of a good performance from recently-launched products in the first nine months of its financial year. However, given the competitive environment the Japanese company is continuing to stick to its full-year forecasts.